Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Published Date: 19 Oct 2025

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel biomarkers may improve diagnosis of gallbladder cancer

2.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

3.

Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.

4.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

5.

Researchers identify a novel biomarker linked to renal cancer recurrence


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot